ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 42889604

Hippo pathway in cancer ferroptosis: from mechanism insights to targeted therapies.

Xu Z and 3 others. Front Med (Lausanne), 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Hippo pathway in cancer ferroptosis: from mechanism insights to targeted therapies. Papers, record 42889604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42889604

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hippo pathway in cancer ferroptosis: from mechanism insights to targeted therapies.
Journal
Front Med (Lausanne)
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-19

Source PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xu ZZiyi
2Yang RRuochen
3Akram HHudabia
4Gu XXinyu

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References108

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138,116,870Ferroptosis: Potential opportunities for natural products in cancer therapy.Phytother Res2024https://conductscience.org/library/papers/38116870PubMed
241,490,559Natural products as modulators of ferroptosis: Therapeutic implications and molecular mechanisms in disease treatment.J Nutr Biochem2026https://conductscience.org/library/papers/41490559PubMed
326,544,935Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.Cell2015https://conductscience.org/library/papers/26544935PubMed
431,341,276Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling.Nature2019https://conductscience.org/library/papers/31341276PubMed
541,642,951KMT2C Loss Promotes NF2-Wildtype Meningioma Progression and Ferroptosis Sensitivity via Epigenetic Repression of Hippo Signaling.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41642951PubMed
639,166,861CMTM5 influences Hippo/YAP axis to promote ferroptosis in glioma through regulating WWP2-mediated LATS2 ubiquitination.Kaohsiung J Med Sci2024https://conductscience.org/library/papers/39166861PubMed
740,414,559Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response.Metabolism2025https://conductscience.org/library/papers/40414559PubMed
837,773,303YAP1 inhibits RSL3-induced castration-resistant prostate cancer cell ferroptosis by driving glutamine uptake and metabolism to GSH.Mol Cell Biochem2024https://conductscience.org/library/papers/37773303PubMed
942,056,242Ginkgetin enhances the antitumor effect of Taxol on human breast cancer MCF-7 cells via ferroptosis mediated by the MDM2-p53-YAP1 axis.Sci Rep2026https://conductscience.org/library/papers/42056242PubMed
1033,863,873O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer.Cell Death Discov2021https://conductscience.org/library/papers/33863873PubMed

1 to 10 of 108

See all 108 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42889604

GET https://conductscience.org/api/papers/v1/42889604/references?page=2

API referenceFor AI assistants